Important COVID-19 Information
Our Statement on COVID-19
COVID-19 is an unprecedented challenge for our communities and nation. Our thoughts and prayers are with everyone who has suffered the loss of family members or friends, and to those that are struggling to recover from the illness.
We are very grateful for the bravery, sacrifice, and hard work of healthcare workers, many of whom Sentry MD is honored to have served over the years. They are the soldiers in this war. To support them, we have made contributions to the American Nurses Foundation and Doctors Without Borders. Both of these organizations have launched initiatives in the United States to provide critically needed resources on the front lines of the pandemic.
Sentry MD stands ready to do its part. We are equipped to track COVID-19 viral tests, immunizations, and antibody tests and will work with you on a solution that meets your needs. Daily, we follow the news, FDA and CDC announcements regarding the development and deployment of tests and vaccines. To help us interpret this information, we have hired a Harvard trained infectious disease expert, who is also an advisor to the World Health Organization. We are also exploring relationships with telehealth and lab companies to see if we can assist our student and employee members gain access to tests and vaccines in a timely and efficient manner as they become available.
The Covid-19 Vaccine's Impact on Compliance
As COVID-19 vaccines become more readily available, this may impact members’ ability to meet and maintain compliance with your organization’s requirements for a period of time.
The Centers for Disease Control and Prevention (CDC) recommends the following:
Other Vaccines Not to be Administered for Two Weeks Before and After the COVID-19 Vaccine
Due to the lack of data on the safety and efficacy of co-administering the mRNA vaccine with other vaccines, the CDC recommends that individuals who receive the COVID-19 vaccine should not receive any other vaccine for at least two weeks before or after other vaccinations. However, there may be some scenarios where a vaccine may be administered to an individual when the benefits of vaccination outweigh possible risks of interaction with COVID-19 vaccine, such as post-exposure scenarios (e.g., hepatitis A, hepatitis B, rabies or tetanus vaccine for wound management).
Deferring TB Testing for Four Weeks After the COVID-19 Vaccine
If TB testing needs to be performed after administration of an mRNA COVID-19 vaccine, the CDC recommends performing a TB Symptom Screen on the employee and deferring the TB skin or blood test (i.e. T-Spot) until four weeks after the COVID-19 vaccine series has been completed. TB skin and blood tests can safely be administered at any point prior to COVID-19 vaccination.
You can reference this information in detail on the CDC website here.